Bell Value-Add Fund VIII Almaden, LLC (CIK: 0002095901) EDGAR, Information, Filings... CompaniesBIO.Com

Bell Value-Add Fund VIII Almaden, LLC

Mailing address
C/O BELL PARTNERS INC., 300 N. GREENE ST., SUITE 1000, GREENSBORO, Delaware, 27401
Phone
336-232-1900
State location
North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

Bell Value-Add Fund VIII Almaden, LLC (CIK: 0002095901) is an American company incorporated in the state of North Carolina. Head office is located at C/O BELL PARTNERS INC., 300 N. GREENE ST., SUITE 1000, GREENSBORO, North Carolina, 27401. Work in the industry N/A. Bell Value-Add Fund VIII Almaden, LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Bell Value-Add Fund VIII Almaden, LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002095901-25-000001 (33 Act) Size: KB	Nov-26-2025	021-565179 251527574

Recent 20 filings. View all Bell Value-Add Fund VIII Almaden, LLC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Bell Value-Add Fund VIII Almaden, LLC overview
Bell Value-Add Fund VIII Almaden, LLC job
Bell Value-Add Fund VIII Almaden, LLC stock
Bell Value-Add Fund VIII Almaden, LLC ownership
Bell Value-Add Fund VIII Almaden, LLC CEO
Bell Value-Add Fund VIII Almaden, LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.